Bromelain inhibits nuclear factor kappa‐B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G2/M arrest to apoptosis
K Bhui, S Tyagi, AK Srivastava, M Singh… - Molecular …, 2012 - Wiley Online Library
Bromelain, obtained from pineapple, is already in use clinically as adjunct in chemotherapy.
Our objective was to test its ability to act as a sole anti‐cancer agent. Therefore, we describe …
Our objective was to test its ability to act as a sole anti‐cancer agent. Therefore, we describe …
Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G (2)/M arrest to apoptosis.
K Bhui, S Tyagi, AK Srivastava, M Singh… - Molecular …, 2011 - europepmc.org
Bromelain, obtained from pineapple, is already in use clinically as adjunct in chemotherapy.
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G (2)/M arrest to apoptosis
K Bhui, S Tyagi, AK Srivastava… - Molecular …, 2012 - pubmed.ncbi.nlm.nih.gov
Bromelain, obtained from pineapple, is already in use clinically as adjunct in chemotherapy.
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G2/M arrest to apoptosis.
KB Kulpreet Bhui, ST Shilpa Tyagi, AK Srivastava… - 2012 - cabidigitallibrary.org
Bromelain, obtained from pineapple, is already in use clinically as adjunct in chemotherapy.
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Our objective was to test its ability to act as a sole anti-cancer agent. Therefore, we describe …
Bromelain inhibits nuclear factor kappa‐B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G2/M arrest to apoptosis
K Bhui, S Tyagi, AK Srivastava, M Singh, P Roy… - Molecular …, 2012 - infona.pl
Bromelain, obtained from pineapple, is already in use clinically as adjunct in chemotherapy.
Our objective was to test its ability to act as a sole anti‐cancer agent. Therefore, we describe …
Our objective was to test its ability to act as a sole anti‐cancer agent. Therefore, we describe …